Aldosterone Breakthrough During Diovan (Valsartan), Tekturna (Aliskiren), and Combination (Valsartan+Aliskiren) Anti-hypertensive Therapy in Patients With Proteinuric Kidney Disease.
Phase of Trial: Phase IV
Latest Information Update: 01 Jul 2014
At a glance
- Drugs Aliskiren (Primary) ; Valsartan (Primary)
- Indications Hypertension
- Focus Pharmacodynamics
- 16 Apr 2014 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 06 Apr 2012 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
- 15 Feb 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.